Gritstone Oncology Announces the Appointment of Veteran Legal Executive Rahsaan Thompson as General Counsel
“Gritstone Oncology, Inc. (GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today announced the appointment of Rahsaan W. Thompson as its executive vice president and general counsel. Mr. Thompson joins Gritstone with over 20 years of experience as corporate counsel,” reports Yahoo Finance.
“Thompson was the general counsel for Opiant Pharmaceuticals, where he was responsible for all legal aspects of corporate strategy, intellectual property, transactions, compliance and regulatory matters. Previously, as the vice president of law for Actelion Pharmaceuticals, he led the Actelion Law Department based in San Francisco, California … Thompson was the associate general counsel at Abraxis Bioscience, before its acquisition by Celegene … Thompson also served as Corporate Counsel at McKesson Corporation. He began his career as an assistant district attorney in the Philadelphia District Attorney’s office. Mr. Thompson obtained his bachelor’s degree from Southern Methodist University and his law degree from Hofstra University. He has served on various non-profit boards and presently serves on the Board of Directors for the Oakland Museum of California Board of Directors as the finance committee chair.
